EngenderHealth: Clinical Trials

13 trials sponsored by EngenderHealth, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 1 terminated, 1 unknown. 8 Not applicable, 2 Phase 3, 1 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 7, Unknown 1
Phase 32Completed 1, Terminated 1
Phase 11Completed 1
Phase 21Completed 1
Phase 41Completed 1

Follow EngenderHealth: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EPI, a Missed Opportunity for Postpartum Family Planning Utilization
counseling for family planning - Contraception
CompletedHawassa University14742020-02-012023-03-03
Safety of Minilaparotomy Provided by Trained Clinical Officers and Assistant Medical Officers: a Non-inferiority Trial
tubal ligation by minilaparotomy - Sterilization, Tubal
Not applicableCompletedEngenderHealth19702016-12-012017-08-03
An Evaluation of Re:MIX: a Teen Pregnancy Prevention Program With Young Parents as Peer Educators, EngenderHealth
Re:MIX, a multi-layer comprehensive teen pregnancy prevention intervention aimed at reducing pregnancy and STIs among youth ages 13-17 - Sexual Behavior, Unprotected Sex
Not applicableCompletedChild Trends6212016-07-012020-05-01
Simplifying the Shang Ring Technique for Circumcision of Men and Boys
Shang Ring, injectable anesthesia (lidocaine 1%), topical anesthesia (lidocaine 2.5%, prilocaine 2.5% cream) - Human Immunodeficiency Virus
Not applicableCompletedEngenderHealth5742015-05-012016-08-03
Using Cultural Ceremonies to Reduce Intimate Partner Violence and HIV Transmission
Intervention to reduce IPV and HIV - HIV
Not applicableCompletedAbdul Latif Jameel Poverty Action Lab68002014-12-012019-01-15
Impact of Microfinance and Participatory Gender Training for Women in Reducing Intimate Partner Violence
Participatory gender training, Microfinance - Maltreatment by Spouse or Partner
Not applicableUnknownLondon School of Hygiene and Tropical Medicine26402014-09-012018-03-26
Use of the Shang Ring Circumcision Device in Boys Below 18 Years Old in Kenya
Male circumcision using the Shang Ring device - Human Immunodeficiency Virus
Not applicableCompletedEngenderHealth802013-07-012015-01-19
A Prospective Field Study: Introducing the Shang Ring in Routine Clinical Settings
Shang Ring - Male Circumcision
Phase 4CompletedFHI 36012002012-02-012012-09-27
Non-inferiority of Short-term Catheterization Following Fistula Repair Surgery
7-day catheterization following fistula repair surgery, 14 day catheterization - Vaginal Fistula
Not applicableCompletedEngenderHealth5242012-01-012015-01-19
Comparison of the Shang Ring With Conventional Surgical Methods
Shang Ring, Male circumcision - Circumcision, Male
Phase 2 / Phase 3CompletedFHI 3604002011-02-012012-03-16
Evaluation of Healing at Three Time Intervals and Potential for Spontaneous Detachment
Shang Ring - Male Circumcision
Not applicableCompletedFHI 360502010-09-012015-03-06
The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
Shang Ring circumcision - Male Circumcision, HIV Prevention
Phase 1CompletedWeill Medical College of Cornell University402009-10-012010-12-06
Screen and Treat for Cervical Cancer Prevention
HPV DNA Testing + Cryosurgery, VIA + Cryosurgery - Cervical Cancer
Phase 3TerminatedColumbia University71232000-01-012015-07-09

Conditions studied

Acquired Immunodeficiency Syndrome (3)  ·  Coitus (1)  ·  Fistula (1)  ·  HIV Infections (1)  ·  Sexual Behavior (1)  ·  Unsafe Sex (1)  ·  Uterine Cervical Dysplasia (1)  ·  Uterine Cervical Neoplasms (1)  ·  Vaginal Fistula (1)

Interventions

Anesthesia (1)  ·  Catheterization (1)  ·  Circumcision, Male (1)  ·  Counseling (1)  ·  Cryosurgery (1)  ·  Family Planning Services (1)  ·  Lidocaine (1)  ·  Prilocaine (1)  ·  Seroconversion (1)  ·  Sterilization, Reproductive (1)

Countries

Kenya (7)  ·  Ethiopia (3)  ·  Tanzania (2)  ·  Zambia (2)  ·  Democratic Republic of the Congo (1)  ·  Guinea (1)  ·  Niger (1)  ·  Nigeria (1)  ·  Sierra Leone (1)  ·  South Africa (1)  ·  Uganda (1)  ·  United States (1)

Top investigators

Mark A Barone, DVM, MS (4)  ·  Marc Goldstein, M.D. (3)  ·  Nicholas Muraguri, MB ChB MPH (2)  ·  Paul Perchal, MA (2)  ·  Quentin Awori, MB ChB (2)  ·  Abebaw Abeje Muluneh, MSc (1)  ·  Abel Gedefaw, MD, MPh (1)  ·  Jared Mogouche, MD ChB (1)  ·  Jared Moguche, MB ChB (1)  ·  Jennifer Manlove, PhD (1)  ·  Jessica Leight, PhD (1)  ·  John M Wekesa, MB ChB MMed (1)  ·  John Masasabi Wekesa, MB ChB MMed (1)  ·  Kasonde Bowa, MSc M. Med FRCS FACS FCS (1)  ·  Lynette Denny, MD (1)

Results publications

PMID 16264158, PMID 20706107, PMID 22433581, PMID 25911172, PMID 26367141, PMID 27331585, PMID 28193198, PMID 29073928, PMID 29609568, PMID 30120168, PMID 31412032, PMID 31412825, PMID 31537372, PMID 32442198, PMID 32810146, PMID 32810147, PMID 33509840, PMID 33782020, PMID 33786810, PMID 34301673, PMID 35428296, PMID 37956111, PMID 38917099